Malaysia Neurology Clinical Trials Market Analysis

Malaysia Neurology Clinical Trials Market Analysis

$ 3999

Malaysia's Neurology Clinical Trials market is projected to grow from $8.41 Mn in 2022 to $13.1 Mn by 2030, registering a CAGR of 5.7% during the forecast period of 2022-30. The market will be driven by a well-developed healthcare infrastructure and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Merck Sharp & Dohme Malaysia.

ID: IN10MYCT005 CATEGORY: Clinical Trials GEOGRAPHY: Malaysia AUTHOR: Vidhi Upadhyay

Buy Now

Malaysia Neurology Clinical Trials Market Executive Summary

Malaysia's Neurology Clinical Trials market is projected to grow from $8.41 Mn in 2022 to $13.1 Mn by 2030, registering a CAGR of 5.7% during the forecast period of 2022-30. Clinical trials are mainly done at universities and government hospitals across Malaysia since the majority of cancer patients are sent to these facilities. The National Pharmaceutical Regulatory Agency is a department of the Ministry of Health with the authority to assess concerns concerning investigational product registration and permission for clinical trial import license (CTIL) or clinical trial exemption (CTX). Malaysia completed 215 clinical trials in 2021, the most ever recorded, ranking the nation second in Southeast Asia only to Singapore in terms of worldwide industry-supported research. In Malaysia, it is estimated that 8.5% of older individuals, or around 260,000 persons, have dementia. Also, there are around 15,000 to 20,000 Parkinson's patients, with a 9.5% growth projected by 2020 due to the elderly being more than 7% of the population.

Neurology clinical trials in Malaysia potentially take place in a variety of hospitals and research organizations around the nation. These studies might concentrate on a variety of neurological illnesses, including stroke, epilepsy, multiple sclerosis, Alzheimer's disease, and Parkinson's disease. In Malaysia, there are various hospitals and research centres that perform neurological clinical trials. University Malaya Medical Centre, Hospital Kuala Lumpur, Hospital Sultanah Bahiyah, Institute of Neuroscience, Sunway Medical Centre and others. The neurology clinical trials market in Malaysia is expected to continue growing in the coming years, driven by factors such as increasing investment in research and development, the rising prevalence of neurological disorders, and the country's favorable regulatory environment.

Malaysia Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

Asian nations have two major advantages for conducting clinical trials: big and diversified patient pools and decreased clinical trial costs. Malaysia has numerous intrinsic characteristics that make it a suitable location for conducting clinical trials, including a multi-ethnic population that is generally treatment-naive, affordable pricing, and established healthcare infrastructure. Moreover, Malaysia has had established expertise, resources, techniques, legislation, and staff in conducting clinical trials for over 20 years. The present Malaysian Economic Transformation Program (ETP) identifies clinical research as one of its primary economic development drivers. As a result, in order to encourage and enhance the number of clinical trials in the nation, the Malaysian government formed Clinical Research Malaysia (CRM) in 2012, with the goal of successfully boosting the timeliness, dependability, and delivery of results for all parties involved.

Market Restraints

Clinical trial funding in Malaysia may be restricted, particularly for those done by indigenous researchers. This might restrict the number of trials that can take place in the nation.  In major cities, Malaysia has numerous well-established research institutes and hospitals; yet, infrastructure in rural regions may be lacking. This may restrict patients in remote locations’ access to clinical trials. Although English is widely spoken in Malaysia, some patients may have low skills in the language, making participation in clinical studies requiring sophisticated informed consent procedures challenging. It also faces competition from other countries in the area, such as Singapore and South Korea, which have comparably advantageous regulatory regimes and well-developed research infrastructure.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis AG
  • Roche
  • Sanofi
  • Merck & Co.
  • Biogen
  • Eli Lilly and Company
  • AstraZeneca
  • Merck Sharp & Dohme Malaysia (MYS)
  • Hovid Berhad (MYS)
  • Pharmaniaga Berhad (MYS)
  • Kotra Pharma (M) Sdn Bhd (MYS)
  • Apex Healthcare Berhad (MYS)

Healthcare Policies and Regulatory Landscape

Clinical trials in Malaysia are governed by the Ministry of Health's National Pharmaceutical Regulatory Agency (NPRA). The NPRA guarantees that all clinical trials performed in Malaysia adhere to the ethical and regulatory standards established by the International Conference on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the World Health Organization (WHO).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 09 October 2023
Updated by: Jay Dalwadi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter